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FIGURE 4. A-C, In the presence of pacemaker or cardioverter defibrillator leads, repair techniques vary and depend on the degree of damage of leaflets. In
the absence of extensive leaflet damage, valve repair is preferred. It usually involves removing (incising) the lead away from the damaged leaflet, and suture
repair of the leaflet defect if present and repositioning the lead by suture fixation against the annulus. Most often suture fixation is in the recess of either the
inferoseptal or anteroinferior commissure. Finally, ringed annuloplasty is performed. Reprinted with permission.1
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Dintraoperatively and would consider TV replacement,
particularly when the patient has already had multiple
previous operations, because we have previously shown a
significant increase in early and late mortality at sternotomy
number 5 and beyond.14,15
CONCLUSIONS
Important TR can occur with a variety of congenital
diagnoses. Early mortality has been low and late survival
is superior with tricuspid repair compared with TV
replacement. Surgical treatment of TR in patients with
congenital heart disease should be performed before the
onset of heart failure.
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Dr Charles D. Fraser (Houston, Tex). I have no disclosures.
I congratulate Dr Said. I have heard him present before, and this
is another example of a beautifully presented paper and elegant
slides and very clear, and I thank you for that.rdiovascular Surgery c Volume 147, Number 1 417
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DYou and your colleagues from the Mayo Clinic have conducted
yet another elegant study and presentation, and all of us who
practice congenital heart surgery owe a debt of gratitude to the
Mayo surgical legacy of innovation and scholarly assessment of
results that was emphasized so nicely by our current president,
Dr Schaff, in his presentation earlier today.
This very large retrospective review of 553 patients with
congenital heart disease and associated TV corrective surgery
provides a window of opportunity for our understanding of the
results after TV operations in an admittedly very heterogeneous
population of patients, as you noted in your presentation and
report.
The central question of focus in all of our minds I expect is
‘‘What are we to do with this information in modifying our
approach to the TV in patients with congenital heart disease?’’
As such, I ask the following questions, and I will ask them in series,
and you can just answer them before going to the next.
The first, in your analysis of the predictors of mortality, you
found TV replacement, repeat sternotomy, previous palliation,
and older age to be risk factors. Given that, with the exception
of valve replacement, this accounts for almost everyonewhomight
ultimately need TV surgery after previous congenital heart
surgery. How are we to use these data in decision-making about
who needs TV surgery?
Dr Said. Thank you, Dr Fraser, for your comments.
First, regarding the predictors of mortality. The message from
this report, despite this heterogeneous group, is we should operate
earlier when significant TR is present and not consider it as a
benign lesion. Heart failure and resternotomy are also predictors
of mortality. Valve repair is almost always preferred, but when
we cannot achieve a successful repair of moderate or less regurgi-
tation, it is reasonable to consider TV replacement, because it
treats right-sided heart failure and might delay the next sternotomy
compared with a poor tricuspid valve repair.
Dr Fraser. Sort of as an extension of that question, and I had the
opportunity to review the report, and I realize you cannot share all
that information in a brief presentation such as this, but in the
report, you noted that your indication for surgery on a TV was
moderate or more TR. However, you also noted that you and others
have clearly shown that, for example, in a patient with late repaired
tetralogy of Fallot who had severe pulmonary valve insufficiency
and a dilating right ventricle, if you placed a competent pulmonary
valve, the TV would get better.
Thus, from this study and your own experience, how did these
data change your thinking and what are your current indications
for intervention on the TV?
Dr Said. In general, the current indication for TV intervention is
the presence of severe TR and symptoms, which can include right-
sided heart failure, decreased exercise tolerance, and/or fatigue.
When TR is secondary, for example, in the setting of pulmonary
regurgitation, we intervene on the TV when grade III or IV TR
is present, a structural abnormality is present with the valve (eg,
chordal rupture or leaflet defect), when severe annular dilatation
is present, or when the pulmonary artery pressures are elevated.
In patients who are apparently asymptomatic, we perform exercise
testing. If the test results are abnormal, we would lean toward TV
repair. When the exercise testing results are normal, we monitor
the RV size with serial imaging, magnetic resonance imaging418 The Journal of Thoracic and Cardiovascular Surgmost commonly. In general, the overall message is earlier inter-
vention for TR.
Dr Fraser. Just to follow up on the indications a bit. Would you
suggest the addition of more objective measures such as stress
testing or magnetic resonance imaging evaluation of the right
ventricle as additional adjuncts to the decision tree?
Dr Said. Yes, we believe magnetic resonance imaging is the
most valuable imaging study, because it provides an accurate
assessment of RV size and function. We find echocardiography
to be most helpful for analysis of the valve anatomy.
Dr Fraser. Finally, is the title a bit misleading? Can we, from
these data in a retrospective analysis, really conclude that it is
the operation that is the difference or is it the patients who undergo
the operation? In other words, is it justified to state that the TV
repair is protective over TV replacement or is it the patients who
require the replacement who are at higher risk, not the operation?
Dr Said. This is another important point. The clinical status of
the patients undergoing surgery, particularly those with right-sided
heart failure, also affects the outcome of reoperation. The pub-
lished data and our study have demonstrated that when surgery
is performed in the setting of class IV heart failure, early mortality
is increased and late survival is reduced. The challenge with this
study is that we had a heterogeneous group of lesions, making it
more difficult to differentiate the outcomes on the basis of repair
versus replacement alone.
Dr Fraser. Again, thank you for a very nice presentation.
Dr Christopher A. Caldarone (Toronto, Ontario, Canada).
May I extend that question just a little bit. You identify congestive
heart failure as 1 of the most important risk factors for death. It is a
modifiable risk factor. Thus, how do you use this information from
2 directions: (1) when a patient presents with congestive heart fail-
ure, do you modify the preoperative management in accordance
with this finding before you bring them to the operating room;
and (2) what patients have too much congestive heart failure to un-
dergo surgery? Are there any patients you would not operate on
and what parameters would you use to exclude a patient from
surgery?
Dr Said.Modifying heart failure before surgery will depend on
the urgency of the situation. Most patients can be medically
optimized as an outpatient. Some patients might be admitted pre-
operatively for medical refinement, including aggressive diuresis
and fluid restriction and, rarely, intravenous inotropic support.
DrCaldarone.Thus, it might be possible through an analysis of
your database to identify when you actually mitigated the effect of
congestive heart failure by those patients who were treated
preoperatively in the aggressive fashion you described?
Dr Said. Yes.
Dr Caldarone. What about patients you had excluded from
surgery, does that ever happen?
Dr Said. Patients who might not be suitable for surgery include
those with significant left ventricular dysfunction, severe RV
dysfunction, and those with liver dysfunction. In general, if the
synthetic function of the liver is intact, we offer surgery. Young
patients with severe biventricular dysfunction or multiple organ
system dysfunction usually undergo evaluation for potential
multiple organ transplantation.
Dr Christopher Baird (Boston, Mass). With regard to the
variables of reoperative TV repair in resternotomy, it seems thatery c January 2014
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Dyou have identified at least resternotomy as a risk factor. With your
large database, were you able to identify how this might guide your
ability to decide whether to repair the valve again or replace the
valve?
Dr Said. Some situations might allow valve repeat repair. In
general, if the leaflet tissue and subvalvular apparatus are pliable
and thin, we attempt repeat repair. The various techniques for
repair of the Ebstein TV can be applied and can help facilitate
valve repair. As the tricuspid leaflet tissue becomes thicker and
more rigid, repeat repair becomes more difficult and replacement
more likely. We have previously published information related to
the sternotomy number and operative risk. The operative risk
increases at the fourth and fifth sternotomy. Consequently, the
sternotomy number also affects the decision to replace versus
repeat repair. We are more likely to replace the TV at the fourth
or fifth redo unless it is a straightforward TV repair with a high
probability of good valve competence.
Dr Pedro J. del Nido (Boston, Mass). Can I follow up on the
issues of functional TR. Can you give us a bit more information
on the patient groups, how many of these patients had left–sided
disease at the same time you were treating the TV and was that
taken into consideration as 1 of the risk factors?
Dr Said. In general, the left ventricular function was normal
for most patients. Approximately 30% of patients underwent a
left-sided procedure; mitral valve surgery was most common.
Importantly, however, this study focused on patients whose main
problem was TR. Specifically, this was their main hemodynamic
lesion and the main indication for surgery. Left-sided lesions,
when present, were usually of moderate severity (eg, moderate
mitral regurgitation) and were addressed during surgery but were
not the main indications for surgery.
Dr del Nido. Because 1 of the points that is well documented
now in adult published studies is functional TR in the face of
mitral disease and that mortality is significantly greater if you
do not address it at the same time as the mitral valve. I am
wondering whether you included the functional TR patients into
a congestive heart failure category. How many of those
patients actually had also either left atrioventricular valve orThe Journal of Thoracic and Casome sort of left-sided heart disease as a part of their congestive
heart failure?
Dr Said. I think that would be about 25% or 30% of these
patients also had left-sided problems. A mitral valve procedure
was performed in 23% and an aortic valve procedure in 9%. In
general, these left-sided lesions were not severe but were abnormal
enough that an intervention was performed because surgery was
advised for right-sided heart failure. It is reasonable to assume
that patients with severe left-sided abnormalities that are corrected
(eg, severe aortic stenosis or severe mitral regurgitation) will result
in some improvement in functional TR.
Dr del Nido. Thus, I guess the next question would be ‘‘If you
have a patient who you are operating on for the left–sided
atrioventricular valve, let us say a canal, who has moderate TR,
they have symptoms, that is why you are operating on the left
side, what would be your decision tree as far as whether to
intervene on the right side as well?
Dr Said. If severe TR is present or the TV has any structural
abnormalities on preoperative imaging or intraoperative transeso-
phageal echocardiography, we repair the TV. If the TR is
moderate and no tricuspid structural abnormality is present and a
severe left-sided lesion is also present that is being fixed, we
usually leave the TV alone.
Dr del Nido. Although many times the problem is not so much
annular, I mean there are subvalvular problems in these patients,
some of the subvalvular apparatus is quite abnormal. In your
images, or at least in the schematics you showed, it seems as if
most of the work that you are focusing on is annuloplasty and
some commissuroplasty. Is there any work that is also done in
the subvalvular apparatus?
Dr Said. Repair maneuvers are directed at the abnormality. In
most situations in this patient cohort, this was at the leaflet or
annular level. The subvalvular apparatus was addressed when a
problem was identified in this area—unsupported segments might
be treated with artificial chordae, mobilization of papillary
muscles, approximation of1 of the papillary muscles to the ven-
tricular septum, or creation of autologous chordae for the tethered
leading edge are some examples of subvalvular maneuvers.rdiovascular Surgery c Volume 147, Number 1 419
